Alexander Gustafsson, who likely was next in line to fight the pound-for-pound king at light heavyweight, called the news “sad … if true” and “a pity for our whole sport.”
He also said Jones (23-1 MMA, 17-1 UFC) should hang up his gloves if the findings are confirmed.
“I do not want to judge him yet – not until we know everything,” Gustafsson (18-4 MMA, 10-4 UFC) told MMABetz.com. “But if it’s true, then it would be best for him to end the sport.”
But considering his previous feelings for Jones, Gustafsson isn’t surprised to be in this position.
“Nothing about that man surprises me anymore,” he said.
Gustafsson said he’ll join the rest of the MMA world in waiting for the results of Jones’ “B” sample, likely to arrive in a few weeks, before he officially weighs in on the fallout.
A second positive would certainly be a setback for Jones, though his team already has signaled it will attempt to prove the positive came from a contaminated supplement, as it did after a first positive steroid test that canceled a title unifier with Cormier at UFC 200.
With Jones knocking out Cormier (19-2 MMA, 8-2 UFC) at UFC 214, Gustafsson appeared to be the strongest candidate to get another title shot. Jones’ camp indicated the Swedish fighter was high on the list of immediate priorities. There were even reports a rematch was in consideration for UFC 218, but UFC President Dana White recently indicated Jones instead was being considered for a heavyweight title fight against champ Stipe Miocic.
White said if Jones can’t beat the latest positive test, he considers Cormier the champion, which means Gustafsson would get a chance to avenge a decision loss to the ex-champ two years ago.
But it also denies Gustafsson a long-desired rematch with “Bones.”
“If there’s somebody I’ve been looking forward to fighting, it’s him,” Gustafsson said. “Revenge in that fight is what I wanted.”view original article >>